EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating traditional omics and machine learning approaches to identify microbial biomarkers and therapeutic targets in pediatric inflammatory bowel disease

Lanlan Li, XuZai Deng, Shuge Wang, Tao Huang

Frontiers in Pharmacology · 14.04.2025 · 16

DOI: 10.3389/fphar.2025.1545392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.04.2025. Verfasst von Lanlan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric inflammatory bowel disease (IBD), especially Crohn’s disease, significantly affects gut health and quality of life. Although gut microbiome research has advanced, identifying reliable biomarkers remains difficult due to microbial complexity.

Methods

We used RNA-seq-based microbial profiling and machine learning (ML) to find robust biomarkers in pediatric IBD. Microbial taxa were profiled at phylum, genus, and species levels using kraken2 on Crohn’s disease and non-IBD ileal biopsies. We performed abundance-based analyses and applied four ML models (Logistic Regression, Random Forest, Support Vector Machine, XGBoost) to detect discriminative taxa. An independent cohort of 36 pediatric stool samples assessed by 16S rRNA sequencing validated top ML results.

Results

Traditional abundance-based methods showed compositional shifts but identified few consistently significant taxa. ML models had better discriminatory performance, with XGBoost outperforming others and pinpointing Orthotospovirus and Vescimonas as key genera. These findings were confirmed in the validation cohort, where only one traditionally noted genus, Actinomyces , maintained significance.

Discussion

Integrating conventional omics with AI-driven analytics boosts reproducibility and clinical relevance of microbial biomarker discovery, opening new possibilities for targeted therapies and precision medicine in pediatric IBD.

Schlagwörter

Stichwörter der Autor:innen

RNA-Seqbiomarkersmachine learningpediatric IBDreproducibilitytherapeutic targets

Autor:innen und Institutionen

  • Department of Pediatrics, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
  • Department of Pediatrics, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Li, L., Deng, X., Wang, S., & Huang, T. (2025). Integrating traditional omics and machine learning approaches to identify microbial biomarkers and therapeutic targets in pediatric inflammatory bowel disease. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1545392

Vancouver

Li L, Deng X, Wang S, Huang T. Integrating traditional omics and machine learning approaches to identify microbial biomarkers and therapeutic targets in pediatric inflammatory bowel disease. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1545392

BibTeX
@article{Li2025,
  author = {Li, Lanlan and Deng, XuZai and Wang, Shuge and Huang, Tao},
  title = {Integrating traditional omics and machine learning approaches to identify microbial biomarkers and therapeutic targets in pediatric inflammatory bowel disease},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1545392}
}
Kostenlos starten →